SEC Form 4 · accession 0001209191-18-037260
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian K Beeler
Officer — EVP, General Counsel
Period of report
Jun 8, 2018
Accepted (ET)
Jun 12, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Jun 8, 2018 | S | 6,545 | $17.00 | D | 88,418 | D | |
| Ordinary Shares | Jun 8, 2018 | S | 8,888 | $18.00 | D | 79,530 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on May 25, 2018.
- F2Includes 2,370 ordinary shares of the Issuer acquired by the reporting person on June 1, 2018 pursuant to an employee stock purchase program.